Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implications

Blood(2020)10.1182/blood.2019004332Source: DataRank Database

The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implications is a research paper published in Blood (2020). On theSindex it has a DataRank of 0. It has been cited 89 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access89 citations

Download PDF

Cite:

Linked data & code

geo nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 6.43)OA: bronzeTopics (48)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Jiye Liu ORCID,Hiroto Ohguchi ORCID,Keiji Kurata ORCID,Mehmet Samur ORCID,Yu‐Tzu Tai ORCID

Live enrichment

PubMed:32844992 PMC:PMC7702477 OpenAlex:https://openalex.org/W3041668408

NCI NIH HHS

Grant: P50 CA100707

NCI NIH HHS

Grant: P01 CA155258

NCI NIH HHS

Grant: R01 CA178264

NCI NIH HHS

Grant: R01 CA050947

FWCI

6.43

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronze

journalhttps://ashpublications.org/blood/article-pdf/136/20/2334/1789776/bloodbld2019004332.pdf

publisherhttps://ashpublications.org/blood/article-pdf/136/20/2334/1789776/bloodbld2019004332.pdf

publisherhttp://ashpublications.org/blood/article-pdf/136/20/2334/1789776/bloodbld2019004332.pdf

journalhttps://doi.org/10.1182/blood.2019004332

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32844992

Fields of Study

Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia ResearchImmune Cell Function and InteractionADP-ribosyl Cyclase 1Antibodies, MonoclonalAntineoplastic AgentsBone MarrowHumansJanus KinasesMembrane GlycoproteinsMultiple MyelomaNitrilesPyrazolesPyrimidinesSTAT Transcription FactorsSignal TransductionTumor Microenvironment

MeSH Terms

Antibodies, MonoclonalAntineoplastic AgentsBone MarrowHumansMembrane GlycoproteinsMultiple MyelomaNitrilesPyrazolesPyrimidinesSignal TransductionSTAT Transcription FactorsADP-ribosyl Cyclase 1Janus KinasesTumor Microenvironment

Keywords

CD38Antibody-dependent cell-mediated cytotoxicityCancer researchDownregulation and upregulationDaratumumabBone marrowBiologyCell cultureImmunologyMolecular biologyCell biologyAntibodyBortezomibMultiple myelomaStem cellMonoclonal antibodyCD34

Sustainable Development Goals

SDG 0: Good health and well-being